Home 2021-02-04T15:34:39+00:00


Consorzio per Valutazioni Biologiche e Farmacologiche (CVBF) is a not-for-profit organisation, founded in 2000 with the mission to perform research and education in the life sciences, biotechnologies, and pharmaceutical fields. Its main focus is drug development for small populations (paediatric and rare diseases).

Consorzio per Valutazioni Biologiche e Farmacologiche (CVBF) mission is to perform innovative research initiatives in the European scenario and in particular to enhance paediatric research from drug discovery and early development to medicines formulations and clinical phases.
CVBF promotes networking within the scientific community and collaboration between stakeholders with an ethical patient-centred approach.
CVBF supports adequate policies pushing towards higher scientific, regulatory, ethical and societal standards for a better implementation of health systems and allocation of resources. CVBF activities are organised within two organisational areas Development&Networking and Clinical Research.

CVBF Brochure

On-going Projects

Latest News

904, 2021


The European Joint Programme on Rare Diseases has launched its first academic education course “Diagnosing Rare Diseases: from the Clinic to Research and back” related to diagnosis in the rare disease’s context. The course will start [...]

2403, 2021

Clinical Trials Information System (CTIS): training programme

EMA has recently launched the CTIS training webpage for all user groups and organisations to facilitate their preparedness. This page contains information about the CTIS training programme and the online self-study material catalogue as foreseen by [...]